NKX2-5, a modifier of skeletal muscle pathology due to RNA toxicity

Human Molecular Genetics

Volumn 24, Issue 1, 2015, Pages 251-264

  Gladman, Jordan T ^a   Yadava, Ramesh S ^a   Mandal, Mahua ^a   Yu, Qing ^a   Kim, Yun K ^a   Mahadevan, Mani S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1A; DOXYCYCLINE; MESSENGER RNA; MICRORNA 1; MUTANT PROTEIN; MYOSIN HEAVY CHAIN; MYOTONIC DYSTROPHY PROTEIN KINASE; RNA; SHORT HAIRPIN RNA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 4; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR TBX20; TRANSCRIPTION FACTOR TBX5; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; NKX2-5 PROTEIN, HUMAN; NKX2-5 PROTEIN, MOUSE;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; EMBRYO; ENHANCER REGION; GENE OVEREXPRESSION; GENE SILENCING; GENOTYPE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; MOUSE; MOUSE EMBRYO; MOUSE MODEL; MUSCLE REGENERATION; MYOBLAST; MYOTONIC DYSTROPHY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SPLICING; RNA TOXICITY; SKELETAL MUSCLE; TOXICITY; WESTERN BLOTTING; WILD TYPE; ANIMAL; CELL LINE; DISEASE MODEL; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; METABOLISM; MODIFIER GENE; MUSCULAR DYSTROPHY; PATHOLOGY; TRANSGENIC MOUSE;

MUS;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GENE KNOCKOUT TECHNIQUES; GENES, MODIFIER; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES; MYOTONIN-PROTEIN KINASE; RNA; TRANSCRIPTION FACTORS;

EID: 84922572659     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu443     Document Type: Article

References (44)

1. Mahadevan, M., Tsilfidis, C., Sabourin, L., Shutler, G., Amemiya, C., Jansen, G., Neville, C., Narang, M., Barcelo, J., O'Hoy, K. et al. (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science, 255, 1253-1255.
2. Davis, B.M., McCurrach, M.E., Taneja, K.L., Singer, R.H. and Housman, D.E. (1997) Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc. Natl. Acad. Sci. USA, 94, 7388-7393.
3. Ranum, L.P. and Cooper, T.A. (2006) RNA-mediated neuromuscular disorders. Annu. Rev. Neurosci., 29, 259-277.
4. Amack, J.D., Paguio, A.P. and Mahadevan, M.S. (1999) Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model. Hum. Mol. Genet., 8, 1975-1984.
5. Amack, J.D. and Mahadevan, M.S. (2001) The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation. Hum. Mol. Genet., 10, 1879-1887.
6. Amack, J.D., Reagan, S.R. and Mahadevan, M.S. (2002) Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD. J. Cell. Biol., 159, 419-429.
7. Amack, J.D. and Mahadevan, M.S. (2004) Myogenic defects in myotonic dystrophy. Dev. Biol., 265, 294-301.
8. Morgan, J.E. and Zammit, P.S. (2010) Direct effects of the pathogenic mutationon satellite cell function in muscular dystrophy. Exp. Cell Res., 316, 3100-3108.
9. Furling, D., Lemieux, D., Taneja, K. and Puymirat, J. (2001) Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscul. Disord. NMD, 11, 728-735.
10. Furling, D., Coiffier, L., Mouly, V., Barbet, J.P., St Guily, J.L., Taneja, K., Gourdon, G., Junien, C. and Butler-Browne, G.S. (2001) Defective satellite cells in congenital myotonic dystrophy. Hum. Mol. Genet., 10, 2079-2087.
11. Thornell, L.E., Lindstom, M., Renault, V., Klein, A., Mouly, V., Ansved, T., Butler-Browne, G. and Furling, D. (2009) Satellite cell dysfunction contributes to the progressive muscle atrophy in myotonic dystrophy type 1. Neuropathol. Appl. Neurobiol., 35, 603-613.
12. Loro, E., Rinaldi, F., Malena, A., Masiero, E., Novelli, G., Angelini, C., Romeo, V., Sandri, M., Botta, A. and Vergani, L. (2010) Normal myogenesis and increased apoptosis in myotonic dystrophy type-1 muscle cells. Cell Death Differ., 17, 1315-1324.
13. Mahadevan, M.S., Yadava, R.S., Yu, Q., Balijepalli, S., Frenzel-McCardell, C.D., Bourne, T.D. and Phillips, L.H. (2006) Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat. Genet., 38, 1066-1070.
14. Kim, Y.K., Mandal, M., Yadava, R.S., Paillard, L. and Mahadevan, M.S. (2014) Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity. Hum. Mol. Genet., 23, 293-302.
15. Gladman, J.T., Mandal, M., Srinivasan, V. and Mahadevan, M.S. (2013) Age of onset of RNA toxicity influences phenotypic severity: evidence from an inducible mouse model of myotonic dystrophy(DM1). PLoS One, 8, e72907.
16. Kanadia, R.N., Shin, J., Yuan, Y., Beattie, S.G., Wheeler, T.M., Thornton, C.A. and Swanson, M.S. (2006) Reversal of RNA missplicing and myotonia after muscleblind overexpression in a mouse poly(CUG) model for myotonic dystrophy. Proc. Natl. Acad. Sci. USA, 103, 11748-11753.
17. Yadava, R.S., Frenzel-McCardell, C.D., Yu, Q., Srinivasan, V., Tucker, A.L., Puymirat, J., Thornton, C.A., Prall, O.W., Harvey, R.P. and Mahadevan, M.S. (2008) RNA toxicity in myotonic muscular dystrophy induces NKX2-5 expression. Nat. Genet., 40, 61-68.
18. Lints, T.J., Parsons, L.M., Hartley, L., Lyons, I. and Harvey, R.P. (1993) Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development, 119, 419-431.
19. Komuro, I. and Izumo, S. (1993) Csx: a murine homeobox-containing gene specifically expressed in the developing heart. Proc. Natl. Acad. Sci. USA, 90, 8145-8149.
20. Kasahara, H., Bartunkova, S., Schinke, M., Tanaka, M. and Izumo, S. (1998) Cardiac and extracardiac expression of Csx/Nkx2.5 homeodomain protein. Circ. Res., 82, 936-946.
21. Lyons, I., Parsons, L.M., Hartley, L., Li, R., Andrews, J.E., Robb, L. and Harvey, R.P. (1995) Myogenic and morphogenetic defects in the heart tubes of murine embryos lacking the homeo box gene Nkx2-5. Genes Dev., 9, 1654-1666.
22. Mankodi, A., Logigian, E., Callahan, L., McClain, C., White, R., Henderson, D., Krym, M. and Thornton, C.A. (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science (New York, N.Y.), 289, 1769-1773.
23. Mehrke, G., Brinkmeier, H. and Jockusch, H. (1988) The myotonic mouse mutant ADR: electrophysiology of the muscle fiber. Muscle Nerve, 11, 440-446.
24. Bulfield, G., Siller, W.G., Wight, P.A. and Moore, K.J. (1984) X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA, 81, 1189-1192.
25. Cruz, J.C., Tseng, H.C., Goldman, J.A., Shih, H. and Tsai, L.H. (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron, 40, 471-483.
26. Lee, K.Y., Li, M., Manchanda, M., Batra, R., Charizanis, K., Mohan, A., Warren, S.A., Chamberlain, C.M., Finn, D., Hong, H. et al. (2013) Compound loss of muscleblind-like function in myotonic dystrophy. EMBO Mol. Med., 5, 1887-1900.
27. Qian, L., Wythe, J.D., Liu, J., Cartry, J., Vogler, G., Mohapatra, B., Otway, R.T., Huang, Y., King, I.N., Maillet,M.et al. (2011) Tinman/Nkx2-5 acts via miR-1 and upstream of Cdc42 to regulate heart function across species. J. Cell Biol., 193, 1181-1196.
28. Biben, C., Weber, R., Kesteven, S., Stanley, E., McDonald, L., Elliott, D.A., Barnett, L., Koentgen, F., Robb, L., Feneley,M. et al. (2000) Cardiac septal and valvular dysmorphogenesis in mice heterozygous for mutations in the homeobox gene Nkx2-5. Circ. Res., 87, 888-895.
29. Stanley, E.G., Biben, C., Elefanty, A., Barnett, L., Koentgen, F., Robb, L. and Harvey, R.P. (2002) Efficient Cre-mediated deletion in cardiac progenitor cells conferred by a 3'UTR-ires-Cre allele of the homeobox gene Nkx2-5. Int. J. Dev. Biol., 46, 431-439.
30. Chen, J.F., Mandel, E.M., Thomson, J.M., Wu, Q., Callis, T.E., Hammond, S.M., Conlon, F.L. and Wang, D.Z. (2006) The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat. Genet., 38, 228-233.
31. Chen, J.F., Tao, Y., Li, J., Deng, Z., Yan, Z., Xiao, X. and Wang, D.Z. (2010) microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J. Cell Biol., 190, 867-879.
32. Rau, F., Freyermuth, F., Fugier, C., Villemin, J.P., Fischer, M.C., Jost, B., Dembele, D., Gourdon, G., Nicole, A., Duboc, D. et al. (2011) Misregulation of miR-1 processing is associated with heart defects in myotonic dystrophy. Nat. Struct. Mol. Biol., 18, 840-845.
33. Poulos, M.G., Batra, R., Li, M., Yuan, Y., Zhang, C., Darnell, R.B. and Swanson, M.S. (2013) Progressive impairment of muscle regeneration in muscleblind-like 3 isoform knockout mice. Hum. Mol. Genet., 22, 3547-3558.
34. Bentzinger, C.F., Wang, Y.X., Dumont, N.A. and Rudnicki, M.A. (2013) Cellular dynamics in the muscle satellite cell niche. EMBO Rep., 14, 1062-1072.
35. Orengo, J.P., Ward, A.J. and Cooper, T.A. (2011) Alternative splicing dysregulation secondary to skeletal muscle regeneration. Ann. Neurol., 69, 681-690.
36. Kalsotra, A., Xiao, X., Ward, A.J., Castle, J.C., Johnson, J.M., Burge, C.B. and Cooper, T.A. (2008) A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc. Natl. Acad. Sci. USA, 105, 20333-20338.
37. Lin, X., Miller, J.W., Mankodi, A., Kanadia, R.N., Yuan, Y., Moxley, R.T., Swanson, M.S. and Thornton, C.A. (2006) Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum. Mol. Genet., 15, 2087-2097.
38. Du, H., Cline, M.S., Osborne, R.J., Tuttle, D.L., Clark, T.A., Donohue, J.P., Hall, M.P., Shiue, L., Swanson, M.S., Thornton, C.A. et al. (2010) Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat. Struct. Mol. Biol., 17, 187-193.
39. Chen, J., Huang, Z.P., Seok, H.Y., Ding, J., Kataoka, M., Zhang, Z., Hu, X., Wang, G., Lin, Z., Wang, S. et al. (2013) mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts. Cir. Res., 112, 1557-1566.
40. Nagel, S., Venturini, L., Przybylski, G.K., Grabarczyk, P., Schmidt, C.A., Meyer, C., Drexler, H.G., Macleod, R.A. and Scherr,M. (2009) Activation of miR-17-92 by NK-like homeodomain proteins suppresses apoptosis via reduction of E2F1in T-cell acute lymphoblastic leukemia. Leuk.Lymphoma, 50, 101-108.
41. Hong, L., Lai, M., Chen, M., Xie, C., Liao, R., Kang, Y.J., Xiao, C., Hu, W.Y., Han, J. and Sun, P. (2010) The miR-17-92 cluster of microRNAs confers tumorigenicity by inhibiting oncogene-induced senescence. Cancer Res., 70, 8547-8557.
42. Kasahara, H., Wakimoto, H., Liu, M., Maguire, C.T., Converso, K.L., Shioi, T., Huang, W.Y., Manning, W.J., Paul, D., Lawitts, J. et al. (2001) Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein. J. Clin. Invest., 108, 189-201.
43. Kasahara, H., Lee, B., Schott, J.J., Benson, D.W., Seidman, J.G., Seidman, C.E. and Izumo, S. (2000) Loss of function and inhibitory effects of human CSX/NKX2.5 homeoprotein mutations associated with congenital heart disease. J. Clin. Invest., 106, 299-308.
44. Briggs, L.E., Takeda, M., Cuadra, A.E., Wakimoto, H., Marks, M.H., Walker, A.J., Seki, T., Oh, S.P., Lu, J.T., Sumners, C. et al. (2008) Perinatal loss of Nkx2-5 results in rapid conduction and contraction defects. Circ. Res., 103, 580-590.